Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the effectiveness of an atorvastatin treatment
regimen involving starting doses between 10 and 80 mg, followed by a single-step titration
(except for subjects started at 80mg), if required
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.